Lv11
10 积分 2025-05-27 加入
The power of combined in silico and AI approaches in prediction of next generation PROTACs: are we there yet?
3小时前
已关闭
Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC)
3小时前
已关闭
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets
6小时前
已完结
Accelerated rational PROTAC design via deep learning and molecular simulations
7小时前
已完结
Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity
9小时前
已完结
The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy
16天前
已完结
A guide to cancer immunotherapy: from T cell basic science to clinical practice
18天前
已完结
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
18天前
已完结
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
27天前
已完结
皖公网安备34019202002308
